Stereoselective pharmacokinetics of (R)-(+)- and (S)-(−)-rabeprazole in human using chiral LC-MS/MS after administration of rabeprazole sodium enteric-coated tablet

Improved quantitative determination of (R)- and (S)-rabeprazole sodium and its metabolites in rat plasma by LC-MS/MS and its application to a toxicokinetic study

There exist two enantiomers: (R)- and (S)-rabeprazole. (R)-rabeprazole offers specific pharmacokinetic advantages and enhanced therapeutic efficacy, warranting further investigation and development. Here, we developed a simple and rapid chiral liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to simultaneously quantify rabeprazole enantiomers and their metabolites (rabeprazole sulfoxide and desmethyl rabeprazole enantiomers) and a LC-MS to quantify rabeprazole thioether. As for the chiral LC-MS/MS method, Chiral-AGP column (150 × 4 mm, 5 μm) was used and its mobile phase was acetonitrile (mobile phase A) and 10 mmol/L ammonium acetate (mobile phase B) (linear gradient profile: 0 min, 10 % B; 5 min, 15 % B; 9 min, 15 % B; 9.01 min, 10 % B; 13 min, 10 % B). The multiple reactions monitoring transitions of m/z 360.3 → 242.1, 376.2 → 240.1, 346.2 → 228.2 and 368.2 → 190.2 were opted for quantifying rabeprazole enantiomers, rabeprazole sulfoxide, desmethyl rabeprazole enantiomers and internal standard omeprazole. The analyte samples were prepared by a simple liquid-liquid extraction method. As for the LC-MS method, analytes were separated on a Inertsil® ODS-3 column (4.6 × 150 mm, 5 μm). The mobile phase was acetonitrile-5 mmol/L ammonium acetate water solution (65:35, v/v). ESI+ was used and ion peaks with m/z 344.2 (rabeprazole thioether) and 285.1 (internal standard diazepam) were monitored. Both these 2 methods were validated for specificity, linearity, precision, accuracy, matrix effect and extraction recovery, and, particularly, the stability of analytes under various conditions. We successfully applied these methods to a 13-week toxicokinetic study of rabeprazole in rats after intravenous administration of (R)- (80, 20, 5 mg/kg/d) and racemic (80 mg/kg/d) rabeprazole sodium. The results showed that rabeprazole and its metabolites did not accumulate in rats. However, desmethyl rabeprazole and rabeprazole thioether showed higher exposure and lower clearance rate in the last administration than in the first one. (R)-rabeprazole showed a higher exposure and a slower elimination rate than (S)-rabeprazole in rats. These findings offer experimental evidence and a theoretical foundation for further preclinical investigations and clinical applications of (R)-rabeprazole.

Chiral separation in the class of proton pump inhibitors by chromatographic and electromigration techniques: An overview

Proton pump inhibitors (PPIs) are benzimidazole-derivative chiral sulfoxides, frequently used in the treatment of gastric hyperacidity-related disorders. Due to their stereoselective metabolism, the eutomeric forms of PPIs can present a more advantageous pharmacokinetic profile by comparison with the distomers or racemates. Moreover, two representatives of the class are used in therapy both as racemates and as pure enantiomers (esomeprazole, dexlansoprazole). A relatively large number of enantioseparation methods employed for the stereoselective determination of PPIs from pharmaceutical, biological, and environmental matrices were published in the past three decades. The purpose of the current overview is to provide a systematic survey of the available chiral separation methods published since the introduction of PPIs in the therapy up to the present. Analytical and bioanalytical methods using different chromatographic and electromigration techniques reported for the enantioseparation of omeprazole, lansoprazole, pantoprazole, rabeprazole, ilaprazole, and tenatoprazole are included. The analytical conditions of the presented methods are summarized in three comprehensive tables, while a critical discussion of the applied techniques, possible mechanism of enantiorecognition, and future perspectives on the topic are also presented.

Cyanoacetylenic Alcohols: Molecules of Interstellar Relevance in the Synthesis of Essential Heterocycles, Amino Acids, Nucleobases and Nucleosides

Cyanoacetylenic alcohols, R1R2C(OH)C≡C–CN, the closest derivatives of cyanoacetylene, an abundant interstellar molecule, are now becoming important compounds in the area of modern organic synthesis that tends to mimic Nature. The presence of highly reactive C≡C and C≡N bonds in close proximity to a hydroxy group endows cyanoacetylenic alcohols with a chemical trinity of mutually influencing functions, leading to a myriad number of chemical transformations. All reactions of cyanoacetylenic alcohols parallel modern organic synthesis, whilst being biomimetic. To react, they do not need transition metals (and in most cases, no metals at all, except for physiologically indispensable Na+ and K+), proceed at ambient temperature and often in aqueous media. Fundamentally, their reactions are 100% atom-economic because they are almost exclusively addition processes. Typically, the cyano, acetylene and hydroxy functions of cyanoacetylenic alcohols behave as an inseparable entity, leading to reaction products with multiple functional groups. This allows hydroxy, carbonyl, carboxylic, imino, amino, amido, cyanoamido, cyano, various P-containing, ether and ester functions, along with double bonds, different fundamental heterocycles (furans, furanones, pyrazoles, oxazoles, pyridines, pyrimidines, purines, etc.) and diverse polycyclic systems to be integrated in a single molecular architecture. This review focuses on an analysis and generalization of the knowledge that has accumulated on the chemistry of cyanoacetylenic alcohols, mostly over the past 15 years.

1 Introduction

2 Nucleophilic Addition to Cyanoacetylenic Alcohols and Subsequent Transformations of the Adducts

3 Annulation with Nonaromatic Nitrogen Heterocycles

4 Annulation with Aromatic Nitrogen Heterocycles

5 Modification of Amino Acids

6 Modifications of Nucleobases

7 Modification of Nucleosides

8 Conclusion